BioAegis Therapeutics Unveils Upcoming Clinical Study of
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS). ...
United Kingdom Christine Lagana Susan Levinson Steven Cordovano Us Department Of Health Society Vulnerability To Global Pandemics
Source: globenewswire.com